BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22383183)

  • 21. SOX9 dependent FOXA1 expression promotes tumorigenesis in lung carcinoma.
    Wang X; Yin Y; Du R
    Biochem Biophys Res Commun; 2019 Aug; 516(1):236-244. PubMed ID: 31221478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Forkhead-box A1 transcription factor is a novel adverse prognosis marker in human glioma.
    Wang L; Qin H; Li L; Feng F; Ji P; Zhang J; Li G; Zhao Z; Gao G
    J Clin Neurosci; 2013 May; 20(5):654-8. PubMed ID: 23510544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of p63 expression in lung cancer by use of complementary DNA and tissue microarray].
    Yu YW; Garber ME; Schlüns K; Pacyna-Gengelbach M; Petersen I
    Zhonghua Bing Li Xue Za Zhi; 2004 Aug; 33(4):324-7. PubMed ID: 15363316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic aberrations in squamous cell lung carcinoma related to lymph node or distant metastasis.
    Boelens MC; Kok K; van der Vlies P; van der Vries G; Sietsma H; Timens W; Postma DS; Groen HJ; van den Berg A
    Lung Cancer; 2009 Dec; 66(3):372-8. PubMed ID: 19324446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases.
    Ferns DM; Heeren AM; Samuels S; Bleeker MCG; de Gruijl TD; Kenter GG; Jordanova ES
    J Immunother Cancer; 2016; 4():78. PubMed ID: 27895918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct prognostic roles and heterogeneity of TTF1 copy number and TTF1 protein expression in non-small cell lung cancer.
    Yoshimura K; Inoue Y; Mori K; Iwashita Y; Kahyo T; Kawase A; Tanahashi M; Ogawa H; Inui N; Funai K; Shinmura K; Niwa H; Suda T; Sugimura H
    Genes Chromosomes Cancer; 2017 Jul; 56(7):570-581. PubMed ID: 28378892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nkx2-1 represses a latent gastric differentiation program in lung adenocarcinoma.
    Snyder EL; Watanabe H; Magendantz M; Hoersch S; Chen TA; Wang DG; Crowley D; Whittaker CA; Meyerson M; Kimura S; Jacks T
    Mol Cell; 2013 Apr; 50(2):185-99. PubMed ID: 23523371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.
    He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D
    Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Forkhead box A1 transcriptional pathway in KRT7-expressing esophageal squamous cell carcinomas with extensive lymph node metastasis.
    Sano M; Aoyagi K; Takahashi H; Kawamura T; Mabuchi T; Igaki H; Tachimori Y; Kato H; Ochiai A; Honda H; Nimura Y; Nagino M; Yoshida T; Sasaki H
    Int J Oncol; 2010 Feb; 36(2):321-30. PubMed ID: 20043065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated expression of ASCL2 is an independent prognostic indicator in lung squamous cell carcinoma.
    Hu XG; Chen L; Wang QL; Zhao XL; Tan J; Cui YH; Liu XD; Zhang X; Bian XW
    J Clin Pathol; 2016 Apr; 69(4):313-8. PubMed ID: 26483561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ratio of FoxA1 to FoxA2 in lung adenocarcinoma is regulated by LncRNA HOTAIR and chromatin remodeling factor LSH.
    Wang R; Shi Y; Chen L; Jiang Y; Mao C; Yan B; Liu S; Shan B; Tao Y; Wang X
    Sci Rep; 2015 Dec; 5():17826. PubMed ID: 26658322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
    Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SMAD3 prevents binding of NKX2.1 and FOXA1 to the SpB promoter through its MH1 and MH2 domains.
    Minoo P; Hu L; Zhu N; Borok Z; Bellusci S; Groffen J; Kardassis D; Li C
    Nucleic Acids Res; 2008 Jan; 36(1):179-88. PubMed ID: 18003659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated cistromic and expression analysis of amplified NKX2-1 in lung adenocarcinoma identifies LMO3 as a functional transcriptional target.
    Watanabe H; Francis JM; Woo MS; Etemad B; Lin W; Fries DF; Peng S; Snyder EL; Tata PR; Izzo F; Schinzel AC; Cho J; Hammerman PS; Verhaak RG; Hahn WC; Rajagopal J; Jacks T; Meyerson M
    Genes Dev; 2013 Jan; 27(2):197-210. PubMed ID: 23322301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amplification and overexpression of CMET is a common event in brain metastases of non-small cell lung cancer.
    Preusser M; Streubel B; Berghoff AS; Hainfellner JA; von Deimling A; Widhalm G; Dieckmann K; Wöhrer A; Hackl M; Zielinski C; Birner P
    Histopathology; 2014 Nov; 65(5):684-92. PubMed ID: 25039982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Prognostic Value of TTF-1/NKX2-1 in Lung Squamous Cell Carcinoma.
    Liao Y; Yang F; Li X; Chen K; Wang J
    Appl Immunohistochem Mol Morphol; 2023 Jul; 31(6):414-420. PubMed ID: 37338116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of NKX2.2 expression in bronchopulmonary typical carcinoid tumors: implications for patients with neuroendocrine tumor metastases and unknown primary site.
    Wang YC; Iezza G; Zuraek MB; Jablons DM; Theodore PR; Bergsland EK; Donner DB; Warren RS; Nakakura EK
    J Surg Res; 2010 Sep; 163(1):47-51. PubMed ID: 20599218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3q26 Amplification and polysomy of chromosome 3 in squamous cell lesions of the lung: a fluorescence in situ hybridization study.
    Pelosi G; Del Curto B; Trubia M; Nicholson AG; Manzotti M; Veronesi G; Spaggiari L; Maisonneuve P; Pasini F; Terzi A; Iannucci A; Viale G
    Clin Cancer Res; 2007 Apr; 13(7):1995-2004. PubMed ID: 17404079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic profiles associated with early micrometastasis in lung cancer: relevance of 4q deletion.
    Wrage M; Ruosaari S; Eijk PP; Kaifi JT; Hollmén J; Yekebas EF; Izbicki JR; Brakenhoff RH; Streichert T; Riethdorf S; Glatzel M; Ylstra B; Pantel K; Wikman H
    Clin Cancer Res; 2009 Mar; 15(5):1566-74. PubMed ID: 19208797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NKX2-1/TTF-1: an enigmatic oncogene that functions as a double-edged sword for cancer cell survival and progression.
    Yamaguchi T; Hosono Y; Yanagisawa K; Takahashi T
    Cancer Cell; 2013 Jun; 23(6):718-23. PubMed ID: 23763999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.